Medical perspectives on hair loss and alopecia

Discussions regarding hair loss have focused on distinguishing between autoimmune conditions, seasonal shedding, and environmental factors.

Initial reports highlight Alopecia Areata, an autoimmune disease affecting approximately 2% of the global population. This condition can cause localized hair loss on the scalp, beard, or body and may lead to psychological impacts like anxiety and depression. In Lima, Peru, the prevalence of Alopecia Areata is estimated to represent between 0.7% and 3.5% of all dermatology consultations.

Subsequent information clarifies misconceptions regarding increased hair loss during August. Medical analysis suggests that late-August shedding is often a manifestation of the seasonal cycle, where hair entering a resting phase in early summer detaches months later. While extreme heat does not cause androgenetic alopecia, environmental factors such as increased sweat and sebum can lead to follicle micro-inflammation, such as seborrheic dermatitis. To combat these issues, specialized treatments like Isdin Lambdapil, Rene Furterer Triphasic, and Vida Shock Biological Capillary Tonic have been noted for supporting the hair cycle.

With September marking Alopecia Awareness Month, medical experts are highlighting the diversity of the condition. Beyond Alopecia Areata, identified forms include androgenetic alopecia (genetic pattern baldness), traction alopecia (caused by hairstyle tension), telogen effluvium (temporary shedding from stress or illness), and alopecia totalis (complete loss of scalp hair). Experts emphasize that identifying the specific underlying cause—whether genetic, hormonal, or environmental—is a critical step before pursuing treatment.